124 related articles for article (PubMed ID: 38211528)
1. Association Between Social Determinants of Health, Distance from Treatment Center, and Treatment Type with Outcomes in Human Papillomavirus Associated Oropharyngeal cancer.
Aden AA; Olawuni FO; Abdel-Halim CN; Zhu AQ; Haller TJ; O'Byrne TJ; Moore EJ; Price DL; Tasche KL; Ma DJ; Lester SC; Gamez M; Neben-Wittich MA; Price K; Fuentes-Bayne HE; Routman D; Van Abel KM
Oral Oncol; 2024 Feb; 149():106675. PubMed ID: 38211528
[TBL] [Abstract][Full Text] [Related]
2. Disparities in survival outcomes among Black patients with HPV-associated oropharyngeal cancer.
Baliga S; Mitchell D; Yildiz VO; Gogineni E; Konieczkowski DJ; Grecula J; Blakaj DM; Liu X; Gamez ME
J Med Virol; 2023 Feb; 95(2):e28448. PubMed ID: 36583477
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
4. Surgical salvage of human papillomavirus-positive oropharyngeal cancer: Secondary analysis of a randomized controlled trial.
Quan DL; Grauer JS; Sunkara PR; Cramer JD
Cancer; 2023 Feb; 129(3):376-384. PubMed ID: 36401615
[TBL] [Abstract][Full Text] [Related]
5. Females Have Worse Overall and Disease-Specific Survival in Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinoma.
Hunter WP; Harris JA; Lee CC; Cheng AC; Peacock ZS
J Oral Maxillofac Surg; 2022 Jul; 80(7):1260-1271. PubMed ID: 35469827
[TBL] [Abstract][Full Text] [Related]
6. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.
Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH
Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic Delay in Human Papillomavirus Negative Oropharyngeal Squamous Cell Carcinoma.
Karp EE; Yin LX; O'Byrne TJ; Lu LY; Routman DM; Lester SC; Neben Wittich MA; Ma DJ; Price KA; Chintakuntlawar AV; Tasche KK; Price DL; Moore EJ; Van Abel KM
Laryngoscope; 2023 Jun; 133(6):1394-1401. PubMed ID: 35851669
[TBL] [Abstract][Full Text] [Related]
9. Disease Profile and Oncologic Outcomes After Delayed Diagnosis of Human Papillomavirus-Associated Oropharyngeal Cancer.
Yin LX; Karp EE; Elias A; O'Byrne TJ; Routman DM; Price DL; Kasperbauer JL; Neben-Wittich M; Chintakuntlawar AV; Price KA; Ma DJ; Foote RL; Moore EJ; Van Abel KM
Otolaryngol Head Neck Surg; 2021 Dec; 165(6):830-837. PubMed ID: 33752487
[TBL] [Abstract][Full Text] [Related]
10. Retropharyngeal lymph node involvement in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Baxter M; Chan JY; Mydlarz WK; Labruzzo SV; Kiess A; Ha PK; Aygun N; Agrawal N
Laryngoscope; 2015 Nov; 125(11):2503-8. PubMed ID: 26227748
[TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus Impact on Temporal Treatment Trends in Oropharyngeal Carcinoma: 2010-2016.
Amin N; Thompson J; Goloubeva O; Witek M; Taylor RJ; Wolf JS; Moyer K; Mehra R; Hatten KM
ORL J Otorhinolaryngol Relat Spec; 2022; 84(6):438-446. PubMed ID: 36067748
[TBL] [Abstract][Full Text] [Related]
12. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.
Sher DJ; Nedzi L; Khan S; Hughes R; Sumer BD; Myers LL; Truelson JM; Koshy M
JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):777-88. PubMed ID: 27368076
[TBL] [Abstract][Full Text] [Related]
13. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
Howard J; Masterson L; Dwivedi RC; Riffat F; Benson R; Jefferies S; Jani P; Tysome JR; Nutting C
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010963. PubMed ID: 27943254
[TBL] [Abstract][Full Text] [Related]
14. The Incidence, Survival, and HPV Impact of Second Primary Cancer following Primary Oropharyngeal Squamous Cell Carcinoma: A 20-Year Retrospective and Population-Based Study.
Andersen L; Jakobsen KK; Carlander AF; Garset-Zamani M; Friborg J; Kiss K; Marvig RL; Olsen C; Nielsen FC; Andersen E; Grønhøj C; Buchwald CV
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680074
[TBL] [Abstract][Full Text] [Related]
15. Hearing Outcomes in a Deintensification Trial of Adjuvant Therapy for HPV-Related Oropharyngeal Squamous Cell Carcinoma.
Lee DS; Mahal RS; Tharakan T; Cathryn Collopy ; Kallogjeri D; Thorstad WL; Adkins DR; Oppelt P; Ley J; Wick CC; Zevallos J
Otolaryngol Head Neck Surg; 2023 May; 168(5):1089-1096. PubMed ID: 36939390
[TBL] [Abstract][Full Text] [Related]
16. Impact of Smoking and Primary Tumor Subsite on Recurrence in HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Lee RH; Salesky M; Benjamin T; El-Sayed IH; George JR; Ha PK; Ryan WR; Heaton CM
Otolaryngol Head Neck Surg; 2022 Apr; 166(4):704-711. PubMed ID: 34182836
[TBL] [Abstract][Full Text] [Related]
17. Quality of Life After Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharynx Cancer.
Silver JA; Bouganim N; Richardson K; Henry M; Mascarella MA; Ramirez-GarciaLuna J; Golabi N; Mlynarek AM; Zeitouni A; Hier MP; Caglar D; Esfahani K; Sadeghi N
JAMA Otolaryngol Head Neck Surg; 2024 Jan; 150(1):65-74. PubMed ID: 38060238
[TBL] [Abstract][Full Text] [Related]
18. Functional Outcomes in Patients with Human Papillomavirus-Associated Oropharyngeal Squamous Cell Cancer Treated with Trimodality Therapy.
Lu JS; Cao AC; Shimunov D; Sun L; Lukens JN; Lin A; Cohen RB; Basu D; Cannady SB; Rajasekaran K; Weinstein GS; Brody RM
Laryngoscope; 2023 Nov; 133(11):3013-3020. PubMed ID: 37129315
[TBL] [Abstract][Full Text] [Related]
19. Treatment Modality Impact on Patient-Reported Quality of Life in Human Papilloma Virus-Associated Oropharyngeal Carcinoma.
Plonowska-Hirschfeld KA; Gulati A; Stephens EM; Ochoa E; Xu MJ; Ha PK; Heaton CM; Yom SS; Chan JW; Algazi A; Kang H; Ryan WR
Laryngoscope; 2024 Apr; 134(4):1687-1695. PubMed ID: 37767815
[TBL] [Abstract][Full Text] [Related]
20. The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer.
Zhou P; Chen DL; Lian CL; Wu SG; Zhang SY
Front Public Health; 2022; 10():900294. PubMed ID: 35958856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
